Tower Bridge Advisors
XBI icon

Tower Bridge Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Tower Bridge Advisors’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.68M Hold
10,645
– – 0.15% 107
2026
Q2 		$1.68M Buy
10,645
+3,675
+53% +$497K 0.15% 106
2026
Q1 		$890K Buy
+6,970
New +$870K 0.09% 129

Other funds holding XBI

Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.8B AUM 32.97% 1-Year Est. Return
Natixis
Natixis Paris, France $28B AUM 27.03% 1-Year Est. Return
Employees Retirement System of Texas
Employees Retirement System of Texas Austin, Texas $12.2B AUM 27.55% 1-Year Est. Return
Investure LLC
Investure LLC Charlottesville, Virginia $1.83B AUM 14.32% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

Tower Bridge Advisors's XBI Position: Q3 2026 in Review

Tower Bridge Advisors held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q3 2026 at 10,645 shares worth $1.68M. The position accounts for 0.15% of the portfolio, ranked #107.

Tower Bridge Advisors first reported a position in XBI in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.68M in Q2 2026. 604 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

  • Tower Bridge Advisors held 10,645 shares of State Street SPDR S&P Biotech ETF worth $1.68M as of Q3 2026.
  • Tower Bridge Advisors left its State Street SPDR S&P Biotech ETF share count unchanged in Q3 2026.
  • State Street SPDR S&P Biotech ETF made up 0.15% of Tower Bridge Advisors's portfolio in Q3 2026, its #107 holding.
  • Tower Bridge Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q1 2026 and has held it in 3 quarters since.
  • Tower Bridge Advisors's State Street SPDR S&P Biotech ETF position peaked at $1.68M in Q2 2026.
  • 604 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Tower Bridge Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.